We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
ProKidney
PROK
$308M
| $61.9K | ﹤0.01% |
37,750
-169,932
| -82% | -$250K |
|
|
KNTE
3852
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $61.7K | ﹤0.01% |
23,187
-35,650
| -61% | -$88.3K |
|
|
ADTH
3853
DELISTED
AdTheorent Holding Co
ADTH
| $61K | ﹤0.01% |
18,993
-53,085
| -74% | -$145K |
|
|
CBIO
3854
Crescent Biopharma
CBIO
$602M
| $60.9K | ﹤0.01% |
+203
| New | +$60.6K |
|
3855
Sundial Growers
SNDL
$325M
| $60.4K | ﹤0.01% |
+30,140
| New | +$44K |
|
3856
Pixelworks
PXLW
$38.8M
| $60.3K | ﹤0.01% |
1,947
-1,925
| -50% | -$51.1K |
|
|
PPTA
3857
Perpetua Resources
PPTA
$2.23B
| $58.5K | ﹤0.01% |
+14,062
| New | +$46.3K |
|
|
AGIG
3858
Abundia Global Impact Group
AGIG
$43.5M
| $58.3K | ﹤0.01% |
4,380
+3,348
| +324% | +$49.1K |
|
|
ASRT
3859
DELISTED
Assertio
ASRT
| $58.1K | ﹤0.01% |
4,039
-1,278
| -24% | -$17.4K |
|
3860
NovaGold Resources
NG
$2.6B
| $57.1K | ﹤0.01% |
+19,029
| New | +$53.6K |
|
3861
Tilray
TLRY
$479M
| $57K | ﹤0.01% |
2,309
-1,809
| -44% | -$34.9K |
|
3862
Babcock & Wilcox
BW
$1.43B
| $56.8K | ﹤0.01% |
50,291
-14,481
| -22% | -$17.9K |
|
|
BRFS
3863
DELISTED
BRF SA
BRFS
| $54K | ﹤0.01% |
+16,563
| New | +$48.8K |
|
3864
Outdoor Holding Co
POWW
$239M
| $53K | ﹤0.01% |
19,275
-29,818
| -61% | -$69.6K |
|
|
OMIC
3865
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $52.4K | ﹤0.01% |
3,395
-608
| -15% | -$9.28K |
|
3866
Trevi Therapeutics
TRVI
$2.49B
| $51.8K | ﹤0.01% |
15,027
-84,464
| -85% | -$188K |
|
3867
Retractable Technologies
RVP
$20.4M
| $50.6K | ﹤0.01% |
42,179
-10,026
| -19% | -$12.2K |
|
|
NKLA
3868
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $49.9K | ﹤0.01% |
+1,600
| New | +$34.4K |
|
|
FLG
3869
PUT
Flagstar Bank National Association
FLG
$5.77B
| $49.9K | ﹤0.01% |
+5,167
| New | +$95.5K |
|
3870
Anixa Biosciences
ANIX
$126M
| $49.6K | ﹤0.01% |
+15,897
| New | +$63.4K |
|
|
TECX
3871
Tectonic Therapeutic
TECX
$573M
| $49.5K | ﹤0.01% |
+3,225
| New | +$51.1K |
|
|
SOL
3872
DELISTED
Emeren Group
SOL
| $49.5K | ﹤0.01% |
+25,626
| New | +$52.3K |
|
|
ACB
3873
Aurora Cannabis
ACB
$165M
| $48.9K | ﹤0.01% |
11,141
+7,906
| +244% | +$30.6K |
|
3874
Sensus Healthcare
SRTS
$49.9M
| $48.4K | ﹤0.01% |
+12,747
| New | +$46.2K |
|
|
CMLS
3875
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $48.2K | ﹤0.01% |
+13,413
| New | +$56.3K |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.